Coldstream Capital Management Inc. Invests $209,000 in Colgate-Palmolive (NYSE:CL)
Coldstream Capital Management Inc. purchased a new stake in Colgate-Palmolive (NYSE:CL) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 3,148 shares of the company’s stock, valued at approximately $209,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Advisory Alpha LLC acquired a new stake in Colgate-Palmolive during the 1st quarter worth $26,000. Balentine LLC bought a new stake in shares of Colgate-Palmolive in the first quarter worth about $36,000. West Bancorporation Inc. acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $38,000. Keebeck Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $39,000. Finally, ERTS Wealth Advisors LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $40,000. Institutional investors and hedge funds own 75.67% of the company’s stock.
Several brokerages have commented on CL. SunTrust Banks raised their target price on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “buy” rating in a report on Friday, May 15th. Credit Suisse Group restated a “sell” rating and set a $67.00 price objective on shares of Colgate-Palmolive in a report on Monday, May 4th. Morgan Stanley boosted their price objective on shares of Colgate-Palmolive from $72.00 to $78.00 and gave the company an “overweight” rating in a research report on Monday, April 27th. Stifel Nicolaus increased their target price on Colgate-Palmolive from $72.00 to $75.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Bank of America raised Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research note on Friday, March 20th. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and nine have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $75.14.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, May 1st. The company reported $0.75 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.73 by $0.02. Colgate-Palmolive had a return on equity of 942.99% and a net margin of 15.86%. The company had revenue of $4.10 billion for the quarter, compared to analysts’ expectations of $4.07 billion. During the same quarter in the prior year, the business posted $0.67 EPS. The business’s revenue was up 5.5% compared to the same quarter last year. Analysts predict that Colgate-Palmolive will post 2.87 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be given a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.44%. The ex-dividend date is Friday, July 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 62.19%.
In other Colgate-Palmolive news, Director Michael B. Polk sold 3,115 shares of Colgate-Palmolive stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $68.08, for a total transaction of $212,069.20. Following the completion of the transaction, the director now directly owns 20,622 shares of the company’s stock, valued at $1,403,945.76. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Chairman Ian M. Cook sold 17,750 shares of the company’s stock in a transaction on Monday, March 30th. The shares were sold at an average price of $65.84, for a total transaction of $1,168,660.00. Following the completion of the transaction, the chairman now owns 856,042 shares in the company, valued at $56,361,805.28. The disclosure for this sale can be found here. Company insiders own 0.78% of the company’s stock.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Article: Intrinsic Value and Stock Selection
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.